Glenmark Life Sciences Limited
MainboardlistedGLSINE03Q201024- DRHP filed19 Apr 21
- RHP filed20 Jul 21
- Open27 Jul 21
- Close29 Jul 21
- Listed06 Aug 21
Issue
- Price band
- ₹695–720
- Issue price
- ₹720
- Face value
- ₹2
- Lot size
- 20
- Issue size
- ₹1,513.6 Cr
- Fresh / OFS
- ₹1,060 Cr / ₹453.6 Cr
- Issue type
- book built
- Registrar
- KFin Technologies Limited
- Exchanges
- BSE, NSE
- Sector
- Healthcare
- Industry
- Pharmaceuticals
Returns
- Listing
- +4.0%
- 1 month
- -7.0%
- 3 months
- -11.8%
- 6 months
- -21.2%
- 1 year
- -38.0%
- Current (03 Nov 26)
- +105.7%
Financials · from the offer document, ₹ crore
| Period | Revenue | EBITDA | PAT | Net worth | Borrowings | Total assets |
|---|---|---|---|---|---|---|
| FY19 | 195.6 | 88.1 | 1,475.4 | |||
| FY20 | 313.1 | 401.7 | 1,725.6 | |||
| FY21 | 351.6 | 752.7 | 1,997.1 |
Reservation · share of the issue the offer document allocates to each category
- qib
- 50%
- nii
- 15%
- retail
- 35%
Subscription
| Category | Exchange | Times subscribed |
|---|---|---|
| nii | NSE | 99.24× |
| qib | reconstructed | 36.97× |
| retail | reconstructed | 14.63× |
| total | reconstructed | 39.15× |
Lead managers
BOB Capital Markets Limited · BofA Securities India Limited · DAM Capital Advisors Limited · GOLDMAN SACHS(INDIA) SECURITIES PVT. LTD. · Kotak Mahindra Capital Company Limited · SBI Capital Markets Limited